Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Patrick C O'Leary
Affiliation
University of California San Francisco
ORCID
Career Start Year
2010
Papers
12
H Index
7
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37131711
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis <i>in vivo</i>.
bioRxiv
2023
37651466
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.
PLoS Pathog
2023
36273492
Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.
Cancer Res
2022
35439318
A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor.
Mol Cancer Ther
2022
36002574
RASA2 ablation in T cells boosts antigen sensitivity and long-term function.
Nature
2022
30305055
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
BMC Cancer
2018
30287919
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.
Br J Cancer
2018
25746038
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
Melanoma Res
2015
25011585
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.
Breast Cancer Res
2014
23547718
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
BMC Cancer
2013
22646761
Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice.
BMC Cancer
2012
20465595
Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis.
Pigment Cell Melanoma Res
2010
1 - 12 of 12
Column Actions
Search
Recommended Authors
Gian Luca Negri
British Columbia Cancer Research Institute
Career Start Year
2013
Number of shared co-authors
2
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year
2013
Number of shared co-authors
0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year
2010
Number of shared co-authors
0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year
2010
Number of shared co-authors
0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
1
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year
2008
Number of shared co-authors
0
Rut Klinger
UCD Conway Institute, University College Dublin
Career Start Year
2006
Number of shared co-authors
9
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
2
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
1
Kris C Wood
Duke University
Career Start Year
2005
Number of shared co-authors
0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year
2004
Number of shared co-authors
0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
1
David W Cescon
Princess Margaret Cancer Centre
Career Start Year
2003
Number of shared co-authors
1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year
2003
Number of shared co-authors
0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year
2002
Number of shared co-authors
1
Alejandra Bruna
CRUK Cambridge Institute, University of Cambridge
Career Start Year
2002
Number of shared co-authors
1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year
2001
Number of shared co-authors
1
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year
2000
Number of shared co-authors
6
Tobias Sj??blom
Uppsala University
Career Start Year
1999
Number of shared co-authors
5
Euan A Stronach
Imperial College London
Career Start Year
1999
Number of shared co-authors
2
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
2
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
1
Shiaw-Yih Lin
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
1
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year
1996
Number of shared co-authors
0
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year
1992
Number of shared co-authors
6
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year
1990
Number of shared co-authors
1
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
1
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year
1989
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers
6
Morgan E Diolaiti
University of California San Francisco
Co-authored papers
5
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
4
Fredrik Pont??n
Uppsala University
Co-authored papers
3
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers
2
Minkyu Kim
University of California san francisco
Co-authored papers
2
Melanie Ott
Gladstone Institute of Virology
Co-authored papers
2
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Co-authored papers
2
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Co-authored papers
2
Karin Jirstr??m
Lund University
Co-authored papers
2
James S Fraser
University of California san francisco
Co-authored papers
2
Julia Carnevale
University of California san francisco
Co-authored papers
2
Manasi P Jogalekar
University of California San Francisco
Co-authored papers
2
Mairin Rafferty
Oncomark Ltd.
Co-authored papers
2
Taha Y Taha
Gladstone Institutes
Co-authored papers
2
Chia-Lin Tsou
Gladstone Institutes
Co-authored papers
2
Galen J Correy
University of California san francisco
Co-authored papers
2
Rahul K Suryawanshi
Gladstone Institutes
Co-authored papers
2
Tanushree Shenoy
University of California san francisco
Co-authored papers
1
Darran P O'Connor
UCD Conway Institute, University College Dublin
Co-authored papers
1
Nupura Kale
Co-authored papers
1
Alan Ashworth
University of California San Francisco
Co-authored papers
1
Mauricio Montano
Gladstone Institutes
Co-authored papers
1
Alexander Marson
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers
1
Hideho Okada
Co-authored papers
1
Benjamin Polacco
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers
1
Ajda Rojc
University of California san francisco
Co-authored papers
1
Tess Williamson
Co-authored papers
1
Maria McCavitt-Malvido
Gladstone Institutes
Co-authored papers
1
Maria McCavitt-Malvido
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers
1
1 - 30